Interpretation of the 2022 diagnostic criteria for multiple system atrophy
Multiple system atrophy(MSA)is a serious and rapidly progressive neurodegenerative disease.The currently used diagnostic criteria are the second edition of MSA diagnostic criteria published in 2008.Although widely recognized in clinical research,they lack sensitivity for early diagnosis of the disease.Reliable early diagnosis of MSA is particularly important for patient care and counseling,recruitment for clinical trials of disease-modifying therapies,and development and validation of diagnostic tools.To overcome the shortcomings of the second edition of the diagnostic criteria,the International Parkinson and Movement Disorder Society developed a new version of diagnostic criteria for MSA,which was published in April 2022.This paper interprets the new MSA diagnostic criteria and examines the scientific research areas that need to be further explored in future research.,which will be important in guiding the management of elderly patients and related research.
Multiple system atrophyProdromal phaseDiagnostic consensus
万方数据
维普
